William Blair & Company
STTK icon

William Blair & Company’s Shattuck Labs STTK Stock Holding History

William Blair & Company’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$378K Buy
+54,471
New +$340K ﹤0.01% 1321

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

William Blair & Company's STTK Position: Q2 2026 in Review

William Blair & Company opened a new position in Shattuck Labs (STTK) in Q2 2026: 54,471 shares worth $378K. The stake represents ﹤0.01% of the portfolio and ranks #1321 among its holdings.

100 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • William Blair & Company held 54,471 shares of Shattuck Labs worth $378K as of Q2 2026.
  • Shattuck Labs was a new William Blair & Company position in Q2 2026.
  • Shattuck Labs made up ﹤0.01% of William Blair & Company's portfolio in Q2 2026, its #1321 holding.
  • 100 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.